Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis

[1]  M. Connelly,et al.  GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.

[2]  M. González-Gay,et al.  Osteoprotegerin Concentrations Relate Independently to Established Cardiovascular Disease in Rheumatoid Arthritis , 2015, The Journal of Rheumatology.

[3]  P. Ridker,et al.  A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events , 2014, Journal of the American Heart Association.

[4]  M. González-Gay,et al.  Independent Relationship of Osteoprotegerin Concentrations with Endothelial Activation and Carotid Atherosclerosis in Patients with Severe Rheumatoid Arthritis , 2014, The Journal of Rheumatology.

[5]  K. Kohara,et al.  An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons , 2013, Annals of clinical biochemistry.

[6]  R. Simpson,et al.  Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. , 2013, The American journal of cardiology.

[7]  G. Cavet,et al.  Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity , 2012, Arthritis care & research.

[8]  M. Budoff,et al.  Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. , 2012, Atherosclerosis.

[9]  P. Raggi,et al.  Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis. , 2011, Atherosclerosis.

[10]  P. Raggi,et al.  Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis , 2011, Arthritis care & research.

[11]  P. Raggi,et al.  Interaction between oxidative stress and high‐density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis , 2010, Arthritis care & research.

[12]  R. Bennett,et al.  1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. , 2010, Journal of proteome research.

[13]  T. Pincus,et al.  Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis , 2010, The Journal of Rheumatology.

[14]  P. Raggi,et al.  Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[15]  Maurizio Cutolo,et al.  Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.

[16]  T. Pincus,et al.  Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[17]  T. Pincus,et al.  Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[18]  Tom Greene,et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) , 2008 .

[19]  T. Pincus,et al.  Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. , 2008, Atherosclerosis.

[20]  F. Ceciliani,et al.  The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. , 2007, Current protein & peptide science.

[21]  T. Pincus,et al.  Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis , 2006, Arthritis research & therapy.

[22]  W. Cromwell,et al.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. , 2006, Clinics in laboratory medicine.

[23]  H. Yamanaka,et al.  Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values , 2006, Annals of the rheumatic diseases.

[24]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[25]  Tebeb Gebretsadik,et al.  Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. , 2005, Arthritis and rheumatism.

[26]  H. Paulus,et al.  Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. , 2005, The Journal of rheumatology.

[27]  S. Lear,et al.  The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. , 2003, Metabolism: clinical and experimental.

[28]  P. Freedson,et al.  Body mass index, but not physical activity, is associated with C-reactive protein. , 2003, Medicine and science in sports and exercise.

[29]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[30]  J. Bastard,et al.  Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. , 2003, Diabetes & metabolism.

[31]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[32]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[33]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[34]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[35]  M H Wener,et al.  The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. , 2000, The Journal of rheumatology.

[36]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[37]  H. Kautiainen,et al.  Continuous progression of radiological destruction in seropositive rheumatoid arthritis. , 1997, The Journal of rheumatology.

[38]  A. Larsen,et al.  How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. , 1995, The Journal of rheumatology.

[39]  M. V. van Leeuwen,et al.  Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. , 1994, The Journal of rheumatology.

[40]  W. Dijk,et al.  Changes in glycosylation of acute-phase proteins in health and disease: Occurrence, regulation and function , 1994 .

[41]  J J Anderson,et al.  The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .

[42]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[43]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[44]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[45]  Jimmy D Bell,et al.  Assignment of resonances for ‘acute‐phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma , 1987, FEBS letters.

[46]  M. Liang,et al.  The erythrocyte sedimentation rate. Guidelines for rational use. , 1986, Annals of internal medicine.

[47]  P. Kimmel,et al.  Factors influencing erythrocyte sedimentation in patients with chronic renal failure. , 1985, Archives of internal medicine.

[48]  Javier Martín,et al.  Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. , 2013, Clinical and Experimental Rheumatology.

[49]  David T Felson,et al.  UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .

[50]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[51]  S. Grundy,et al.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[52]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[53]  J. Vion-Dury,et al.  Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: a proton NMR spectroscopy study. , 1991, Biochimie.